Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin

The Journal of Allergy and Clinical Immunology

Volumn 82, Issue 1, 1988, Pages 101-109

  Michel, Laurence ^a   De Vos, Christine ^a   Rihoux, Jean Pierre ^a   Burtin, Claude ^a   Benveniste, Jacques ^a   Dubertret, Louis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; COMPOUND 48-80; POLLEN ANTIGEN; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ALLERGY; BIOLOGICAL MODEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOLOGY; EOSINOPHIL; ETIOLOGY; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MALE; MONOCYTE; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN TEST;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CETIRIZINE; EOSINOPHILS; FEMALE; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HUMAN; HYDROXYZINE; HYPERSENSITIVITY, IMMEDIATE; MALE; PLATELET ACTIVATING FACTOR; SKIN; SUPPORT, NON-U.S. GOV'T;

EID: 0023784858     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(88)90058-9     Document Type: Article

References (51)

1. Activation of mast cells for mediator release through IgE receptors
2. Studies on the sensitization of patients with bronchial asthma to bacterial proteins as demonstrated by the skin reaction and the methods employed in the preparation of these proteins
3. The correlation between skin tests, bronchial provocation tests, and the serum level of IgE specific for common allergens in patients with asthma
4. The nature of the antigen-antibody complexes initiating the specific wheal-and-flare reaction in sensitized man
5. The late phase of the immediate wheal-and-flare skin reaction
6. Late cutaneous allergic responses in isolated IgE-dependent reactions
7. The mast cell and its mediators
8. The accumulation of eosinophils as an allergic response to allergen applied to the denuded skin surface
9. Leukocyte activation in allergen-induced late-phase asthmatic reactions
10. Contribution of macrophages to immediate hypersensitivity reaction
11. From parasites to allergy: a second receptor for IgE
12. Histamine and antihistamines
13. An evaluation of the pharmacologic inhibition of the immediate and late cutaneous reaction to allergen
14. Inhibition of histamine and allergen skin wheal by cetirizine in four animal species
15. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares experimental dermographism and cold-induced urticaria
16. Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl
17. Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils
18. A high-sampling-rate automated continuous flow fluorometric technique for the analysis of nanogram levels of histamine in biological samples
19. Neutrophil studies in psoriatics: in vivo migration, phagocytosis, and bacterial killing
20. A method of studying leukocytic functions in vivo
21. Leukocytedependent histamine release from rabbit platelets: the role of IgE, basophils, and a platelet-activating factor
22. Individual comparisons by ranking methods
23. The mast cell
24. Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions
25. Studies on the mechanism of hypersensitivity phenomena IX Histamine release from human leukocytes by ragweed pollen antigen
26. Histamine release produced in human skin by compound 48/80
27. Human skin mast cells: their dispersion, purification, and secretory characterization
28. 2 histamine antagonists on symptomatic dermographism
29. In vitro and in vivo studies of mediator release from human mast cells
30. Biology and biochemistry of platelet-activating factor
31. Activities that metabolize platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore
32. Platelet-activating factor release in allergic skin sites in humans [Abstract]
33. PAF-acether today—relevance for acute experimental anaphylaxis
34. Inflammatory characteristics of platelet-activating factor (PAF-acether) in human skin
35. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man [Letter]
36. PAF-acether is a potent chemotactic factor for human eosinophils
37. Platelet-activating factor: a potent chemotactic and chemokinetic factor for human eosinophils
38. Effects of platelet-activating factor on the chemotaxis of normodense eosinophils from normal subjects
39. Modification of the late asthmatic response and bronchial hypersensitivity by BN52021, a platelet-activating factor antagonist [Abstract]
40. The selective eosinophil chemotactic activity of histamine
41. Modulation of inflammatory and immune responses by histamine
42. Eosinophilia
43. Eosinophil polymorphonuclear leukocyte function in immediate hypersensitivity
44. The role of the eosinophilic leukocyte in bronchial asthma
45. Synthesis and eosinophil granule substances
46. Formation of PAF-acether by human eosinophils [Abstract]
47. Increased biosynthesis of platelet-activating factor in activated human eosinophils
48. Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation
49. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein
50. Functional and biochemical properties of selected protein constituents of human eosinophils